GelStat Corporation is a publicly traded company trading under the symbol ("GSAC") that is engaged in research, development, marketing and ...
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
GelStat Corporation is a publicly traded company trading under the
symbol (“GSAC”) that is engaged in research, development,
marketing and branding of innovative over-the-counter (OTC)
consumer healthcare products addressing very large markets.
Presented by:
Larry Gershman
May 2014 Gerald Kieft
1
Disclaimer
THIS PRESENTATION IS FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT CONSTITUTE AN
OFFER OR SOLICITATION. FURTHERMORE, ALL INFORMATION CONTAINED IN THIS PRESENTATION
CONSTITUTES CONFIDENTIAL INFORMATION OF THE COMPANY. ANY REPRODUCTION OR
DISTRIBUTION OF THIS PRESENTATION, IN WHOLE OR IN PART, OR THE DIVULGING OF ANY OF ITS
CONTENTS WITHOUT THE PRIOR WRITTEN CONSENT OF THE COMPANY IS STRICTLY PROHIBITED
THIS REPORT MAY CONTAIN FORWARD-LOOKING STATEMENTS, PARTICULARLY AS RELATED TO
PRO FORMA FINANCIAL STATEMENTS, EARNINGS ESTIMATES AND BUSINESS EXPECTATIONS,
WITHIN THE MEANING OF SECTION 27A OF THE SECURITIES ACT OF 1933 AND SECTIONS 21E OF THE
SECURITIES EXCHANGE ACT OF 1934, AND ARE SUBJECT TO THE SAFE HARBOR CREATED BY THESE
SECTIONS. ANY STATEMENTS THAT EXPRESS OR INVOLVE DISCUSSIONS WITH RESPECT TO
PREDICTIONS, EXPECTATIONS, BELIEFS, PLANS, PROJECTIONS, OBJECTIVES, GOALS, ASSUMPTIONS,
FUTURE EVENTS, OR PERFORMANCE ARE NOT STATEMENTS OF HISTORICAL FACT AND MAY BE
"FORWARD LOOKING STATEMENTS." FORWARD LOOKING STATEMENTS ARE BASED ON
EXPECTATIONS, ESTIMATES, AND PROJECTIONS AT THE TIME THE STATEMENTS ARE MADE THAT
INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS OR
EVENTS TO DIFFER MATERIALLY FROM THOSE PRESENTED HEREIN.
2
Overview
Public Company Trading on OTC (Symbol:GSAC)
Proven Management
Effective Products
Solid Clinical Data
Robust Product Pipeline
Very Large Markets
3
Officers and Directors
Larry Gershman, CEO and Chairman of the Board
Gerald N. Kieft, Chief Financial Officer, Director
Adrian Goldfarb, Director & Head of Audit Committee
William Colucci, Director
Paul Bucha, Director
Collectively, the aforementioned own over 50% of the company
and are currently receiving minimal cash compensation.
4
Leadership – Officers
Larry Gershman has been one of the most successful people in the world of advertising,
integrated marketing, promotions, direct response and digital media. He has won the coveted
Promotion of the Year Award an unprecedented 6 times and was Promotion Man of the Year
twice. His long and varied client list includes: Revlon, Gillette, Ford, Mazda, Citigroup, Kraft,
Pepsi, RC Cola, Burger King and McDonald's to name but a few.
Larry's management skills have been proven repeatedly during his career having owned, built or
managed some of the most successful marketing companies in the World, including Ogilvy &
Mather, Integrated Communications Group, Marden Kane, The Howard Marlboro Group,
Larry Gershman
Integrated Marketing & Promotional Solutions ("IMPS") among others.
Chairman & CEO
Gerald N. Kieft, Chief Financial Officer and Director
Mr. Kieft was the interim CEO for GelStat Corporation from June of 2008 until June of 2013. Mr.
Kieft began his career as an analyst for the Loan Source in 1991, providing debt-funding sources for
small businesses through Small Business Association (SBA) loans. Subsequently, Mr. Kieft has
founded, built and managed a number of successful companies as well as worked as a buy-side
analyst for a hedge fund, a sell-side analyst for a boutique brokerage firm and as a consultant to
high net worth individuals and emerging growth companies at a number of financial institutions
including Prudential Securities, Legg Mason Wood Walker and Raymond James & Associates.
Throughout his career in the finance industry, Mr. Kieft has helped numerous emerging growth
companies obtain financing and investors. Mr. Kieft is a graduate of Eastern Illinois University,
where he earned a Bachelor of Science in Business degree, majoring in Finance, as well as a Bachelor
of Arts degree, majoring in Economics.
5Leadership – Advisors/Consultants
Roger Cady, M.D, Chief Medical Advisor
Dr. Cady is the founder of Headache Care Center, Clinvest, and Primary Care Education. He is a graduate of the Mayo Medical
School, and is Board Certified by the American Board of Family Practice. His board certification in Headache Medicine was
awarded by the United Council for Neurologic Subspecialties, and he holds a Certificate of Added Qualification through the
National Board of Certification in Headache Management. He is a member of multiple medical associations, including the
American Medical Association, the National Headache Foundation, the American Headache Society, the American Academy
of Pain Management, and the American Academy of Family Physicians. Dr. Cady is best known in the medical community for
his pivotal contributions in the field of headache and migraine management. He was the co-recipient of the prestigious Wolff
Award in 2000 from the American Headache Society for his research entitled "The Spectrum of Headache". He is well-
published and has presented countless lectures and seminars around the world on headache, migraine, and other chronic
disorders, and continues to be the principal investigator in numerous multi-center research studies. Dr. Cady currently serves
on 12 Advisory Boards and is a member of the Board of Directors for the National Headache Foundation.
Tim Sweeney, Consultant – Branding and Marketing
Tim Sweeney is a senior management executive with over 25 years’ experience in marketing and sales. He started his career in
advertising with Best Foods International’s Hellmann’s Mayonnaise and Skippy Peanut Butter brands. Over the last 15years,
he has concentrated on the Direct Response (DR) advertising of natural supplements as well as health and beauty aids
working as in-house marketing consultant for the clients of Vita Quest International, the largest private label natural
supplemental manufacturer in the U.S. This vast experience as enabled him to steward products from basic concept to
national retail expansion of direct response developed brands such as H57 Hoodia, George Foreman’s LifeShake, and the
Quick Trim Diet Plan with the Kardashian sisters.
6Initial Opportunities – U.S. Market
• GelStat Migraine - Decision Resources, one of the world’s leading research and
advisory firms for pharmaceutical and healthcare issues, expects that the market for
migraine therapies to increase from $3.3 billion in 2011 to $5.8 billion in 2021 in the
United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
• Chews 2 Lose – According to Marketdata Enterprises, Inc. , a leading independent
market research publisher of “off-the-shelf” studies about service industries since 1979,
an estimated 75 million dieters spent $2.7 billion in 2010 on diet pills and meal
replacements.
• All Natural Speed – According an article published by Companies and Markets.com,
the US energy drinks market is estimated to have increased by 60% over the past four
years, hitting an estimated value of $12.5 billion in 2012. The industry is expected to
continue this growth path, by rising to a valuation of $21.5 billion by 2017.
• GelStat Sleep - The total over-the-counter market for sleep aids alone reached $604
million in 2008, an increase of 9 percent over 2007, according to Packaged Facts, a
division of Rockville, Md.-based Market Research Group.
7Opportunity - Products
GelStat® Migraine
Benefits of Product
Used as abortive product with fast onset of action
No reported side effects
Cost effective migraine relief
Available OTC, without a prescription
Pre-measured, single-dose dispensers are convenient, safe and effective
Unique sub-lingual administered product
Prevents risk of rebound headaches
Clinically validated effectiveness
3rd party validation of effectiveness
Vast amount of testimonials Patent # 7,192,614 on
Patented product GelStat Migraine
(compositions and
methods of treatment to
alleviate or prevent
migrainous headaches
www.migraines.org and their associated
symptoms).
www.TeriRobert.com
8Clinical Support
Migraine
Two clinical trials have been conducted on GelStat® Migraine, both
yielding positive results. The first was an open label study that was
performed by Roger K. Cady, M.D. and Curtis P. Schreiber, M.D., both of
ClinVest, the research division of the Headache Care Center in
Springfield, Missouri.
The second was a double blind study performed by Dr. Sheena K. Aurora.
Dr. Aurora is a co-director of the Swedish Headache Center in Seattle, a
specialty headache clinic that treats more than 3,000 patients each year.
She is also board-certified in neurology and electro-diagnostic medicine
as well as has additional qualifications in clinical neurophysiology.
9Testimonials
Migraine
“As an very active person and a professional ski patroller I need quick relief from migraines
and find that Gelstat provides quick relief without the side effects that prescription
medication causes. I highly recommend it to migraine sufferers.” - Susie M.
"This is a great product. I have had migraines since I was 8. It works and let's me get on with
my day. I wish I would have known about it sooner.” – Rachelle
“I have tried every product available for my migraines. Nothing works. Even prescription
medications from my doctor didn’t help. I’m tired of using Advil & Motrin. I finally found
the answer to my problem - GelStat.” – Roxanne, New York
10Opportunity - Products
Chews 2 Lose
NEED
IMAGE
Innovative Appetite Suppressant Gum
Designed to work with ALL diet plans
#1 reason diets fail is cheating
Easy to use, just simply chew gum
75 Million American Dieters Annually
Custom formulation buying direct from
manufacturer delivers significant margins
11Opportunity - Products
All Natural Speed
All Natural Energy Product in Capsule Form
Enormous Market Size - 5-Hour Energy alone reported over $1 billion
in retail sales 2012
Enormity of category opens opportunity to address specific quick fix
energy user groups
Edgy Product Targeting College Students and Gamers
Highly Specialized Irreverent Advertising Campaign
Available OTC without a Prescription
Custom formulation buying direct from manufacturer delivers
significant margins
Expected to be Available in the 2nd Quarter of 2014
12Opportunity - Products
GelStat® Sleep
Reduced Time to Fall Asleep
Increased Quality of Sleep
No Drowsiness or “Hangover Feeling” the Following Day
Available OTC without a Prescription
Numerous Testimonials
Significant Margins
Large Market Size
Potential usage for professionals with irregular sleep
patterns (pilots, nurses, machine operators, military
personnel.)
Expected to be Available in the 3rd Quarter of 2014
13Objectives/Timing
• Launch marketing efforts for Chews 2
Lose in Q2 2014.
• Launch All Natural Speed in Q2 2014.
• Launch GelStat Sleep in Q3 2014
• Build product pipeline through licensing
agreements and acquisitions.
• The overall objective is successfully
launch 10 products over the next 3-5
years that each generate $10 million plus
in revenue.
14Timeline & Goals For 2014
- Redesign website for GelStat Migraine (Done)
- Design and launch Migraine Advocacy website - www.migraineadvocate.org (Done)
- Engage distributor for GelStat Migraine (Done)
- Complete packaging and initial commercial production run for Chews 2 Lose (Done)
- Complete website landing pages and test creative for Chews 2 Lose ad campaigns
- Engage distributor for Chews 2 Lose
- Complete creative tests on Chews 2 Lose and then launch full ad campaigns
- Engage Public Relations firm to build brand recognition and drive PR campaigns
- Complete packaging and initial commercial production run for All Natural Speed
- Engage distributor for All Natural Speed
- Re-launch GelStat Sleep
Reinvest cash flows into ad spend and
drive revenue growth.
1st 2nd 3rd 4th
Quarter Quarter Quarter Quarter
15Marketing Strategy
The Hybrid Direct Response Retail Support (HDRRS) campaign
is the best approach for any brand GelStat has an interest in
bringing to retail. The HDRRS principle is simple; combine a
direct response sales and branding campaign with strategic
rollout into select retail locations.
Why follow this approach? Because there have not been any
brands successful at the retail level that have first failed in Direct
Response (DR); however, there have been several hugely
successful Health and Beauty Aid (HBA) retail brands that were
cultivated from Direct Response campaigns.
To that end, our primary marketing strategy for our current and
future products is to begin with a direct-to-consumer campaign
and then move into select retail markets over time.
16Internet Commerce – GelStat Migraine
WWW.TRYGELSTATMIGRAINE.COM 17Capital Structure
Common Stock:
500,000,000 Shares authorized
300,000,000 Shares issued and outstanding 3/27/2014
55,000,000 Shares in market at CEDE
Preferred Stock: None Issued
Debt: None
18Raise and Use of Proceeds
The Company is currently seeking up to $2,000,000 in funding from accredited
investors via subscription agreement at $.035 per share of Common Stock.
The funds with be used:
• To fund advertising campaigns
• To purchase inventory
• To fund synergistic acquisitions
• For general working capital needs
19Investment Considerations
A full portfolio of fully developed products
Two clinical studies yielding positive results on GelStat Migraine
GelStat Migraine is supported by leading consumer advocacy groups
Positive feedback from customers
Significant existing inventory that can be used to generate cash flows
Low monthly “over head” burn rate
Investor friendly business model and management team
Fully developed website/e-commerce platform
Low investor entry point
Very large markets
Unlimited potential with branding/distribution strategy
203545 SW Corporate Parkway
Palm City, FL 34990
(772) 283-0020 (Tel)
(772) 219-3579 (Fax)
info@gelstat.com
Websites:
www.GelStat.com
www.GelStatMigraine.com
21You can also read
